XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021 $ 366,327 $ 41 $ 413,967 $ (270) $ (47,411)
Beginning balance (in shares) at Dec. 31, 2021   41,243,137      
Exercise of common stock options 1   1    
Exercise of common stock options (in shares)   6,405      
Vesting of restricted shares 503   503    
Vesting of restricted shares (in shares)   144,118      
Stock-based compensation 3,958   3,958    
Unrealized gain (loss) on available-for-sale securities, net (1,297)     (1,297)  
Net loss (13,410)       (13,410)
Ending balance at Mar. 31, 2022 356,082 $ 41 418,429 (1,567) (60,821)
Ending balance (in shares) at Mar. 31, 2022   41,393,660      
Beginning balance at Dec. 31, 2022 320,740 $ 42 432,703 (1,535) (110,470)
Beginning balance (in shares) at Dec. 31, 2022   41,616,260      
Exercise of common stock options $ 1,580   1,580    
Exercise of common stock options (in shares) 148,649 148,649      
Vesting of restricted shares $ 134   134    
Vesting of restricted shares (in shares)   37,898      
Stock-based compensation 5,473   5,473    
Unrealized gain (loss) on available-for-sale securities, net 796     796  
Net loss (17,459)       (17,459)
Ending balance at Mar. 31, 2023 $ 311,264 $ 42 $ 439,890 $ (739) $ (127,929)
Ending balance (in shares) at Mar. 31, 2023   41,802,807